期刊文献+

1%盐酸布替萘芬溶液治疗趾间型足癣和体股癣随机双盲对照临床试验 被引量:10

A Double Blind Randomized Controlled Clinical Trial of Butenafine Hydrochoride 1% Solution in the Treatment of Interdigital Tinea Pedis and Tinea Corporis & Cruris
下载PDF
导出
摘要 目的:评价1%盐酸布替萘芬溶液治疗趾间型足癣和体股癣的疗效及安全性,并与1%联苯苄唑溶液对比。方法:每天外用1次,疗程体股癣2周,足癣4周,随访2周。对照组30例。体股癣试验组32例,对照组32例。结果:试验组对足癣,在停药时的临床有效率87.1%(对照组93.3%),真菌学清除率90.3%(对照组93.3%)。在停药后2周分别为100%(对照组96.7%)和 100%(对照组96.7%)。试验组对体股癣,在停药时的临床有效率96,9%(对照组87.5%),真菌学清除率96.9%(对照组93.8%)。在停药后2周分别为100%(对照组90.6%)和100%(对照组96,9%)。试验组药物不良反应发生率12.5%(对照组16.1%),表现为局部轻度刺激。结论:1%盐酸布替萘芬溶液治疗趾间型足癣和体股癣的疗效和安全性与1%联苯苄唑 溶液相似。 OBJECTIVE:This study is to assess the efficacy and safety of butenafine hydrochoride 1% solution.METHODS: Butenafine hydrochoride 1% solution was compared with bifonazole 1% solution and was applied once daily for 4 weeks in the treatment of interdigital tinea pedis and for 2 weeks in the treatment of tinea corporis & cruris, both treatment groups had 2 weeks of follow-up observation after the end of treatment.31 cases in trial group and 30 cases in control group were enrolled for tinea pedis;32 cases in the trial group and 32 cases in control group were enrolled for tinea corporis & cruris.RESULTS:Overall effective treatment rates for tinea pedis at end of treatment were 87. 1% in trial group and 93.3% in control group;and 100% versus 96.7% at follow-up 2 weeks respectively. Mycological cure rates for tinea pedis at the end of treatment were 90.3% in trial group and 93.3% in control group; and 100% versus 96.7% at follow-up 2 weeks respectively. Overall effective treatment rates for tinea corporis & cruris at end of treatment were 96.9% in trial group and 87.5% in control group; and 100% versus 90.6% at follow-up 2 weeks respectively. Mycological cure rates for tinea corporis & cruris at end of treatment were 96.9% in trial group and 93.8% in control group; and 100% versus 96.9% at follow-up 2 weeks respetively. An local irritation occurred equally treatments but was well tolerated by the patients. Adverse reaction rate were 12.5% in trial group and 16. 1% in control group.CONLUSION: The efficacy and safety of butenafine hydrochoride 1% solution in the treatment of interdigital tinea pedis and tinea corporis & cruris is as same as bifonazole 1% solution.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2001年第5期344-347,共4页 The Chinese Journal of Clinical Pharmacology
关键词 布替萘芬溶液 药物治疗 联苯苄唑 趾间型足癣 体股癣 比较 butenafine hydrochoride bifonazole interdigital tinea pedis tinea corporis & cruris.
  • 相关文献

参考文献3

  • 1[1]Greer DL, Weiss J, Rodriguez DA, et al. A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine, a new antifungal agent. J Am Acad Dermatol, 1997;37:231~235.
  • 2[2]Tschen E, Elewski B, Gorsulowsky DC, et al. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream. J Am Acad Dermatol, 1997;36:S9~S14.
  • 3[3]Lesher JL Jr, Babel DE, Stewart DM, et al. Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled double-blind trial. J Am Acad Dermatol, 1997;36:S20~S24.

同被引文献55

引证文献10

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部